News Regeneron, Illumina join $320m Truveta investment Regeneron and Illumina have joined a major investment in health data specialist Truveta that will support the creation of a major new genome project.
News Algorithm spots common sleep disorder linked to dementia An AI algorithm can help detect REM sleep behaviour disorder, which affects millions of people and is a warning signal for neurological diseases.
News World's largest proteomics trial launched by UK Biobank A major population proteomics study using UK Biobank patient samples backed by 14 pharma companies has launched today.
News EU pharma calls for speedy shift to digital package inserts Pharma groups have called for EU adoption of electronic product information (ePI) to take place within four years in a new position paper.
News J&J says Rybrevant combo has survival edge over Tagrisso Rybrevant plus Lazcluze extended median OS by more than a year compared to Tagrisso in the MARIPOSA trial in treatment-naive, EGFR-mutated NSCLC.
News US reports its first fatal case of H5N1 bird flu A man in Louisiana has become the first recorded fatality in the US attributed to the H5N1 strain of bird flu.
Sales & Marketing Biotech is back, with Craig Ackerman In Philadelphia this month, pharmaphorum spoke with Craig Ackerman, a partner at the Alexander Group, about launches, AI best practices, and more.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.